CX9-27670-06725
4 vaccinations
10 coded responses
39 check-ins
10 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 730 / OK
- Registered
- 2021-03-13
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-13
Registered in v-safe
-
2021-03-13
Dose 1 — Pfizer-BioNTech
-
2021-03-13
Survey response — day 0, dose 1MedDRA: Headache, Pre-existing disease, Seasonal allergy — Feeling: Fair · HeadacheFree text: Headache pre-existing due to seasonal allergiesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-14
-
2021-03-15
Survey response — days 1–6 daily, dose 1MedDRA: Restlessness — Feeling: GoodFree text: RestlessnessMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-17
- 2021-03-18
-
2021-03-19
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Chills, Fatigue or tirednessAdult check-in
- 2021-03-20
- 2021-03-27
-
2021-04-03
Dose 2 — Pfizer-BioNTech
- 2021-04-03
-
2021-04-04
Survey response — days 1–6 daily, dose 2MedDRA: Hyperhidrosis, Malaise, Tachycardia — Feeling: Fair · Site: PainFree text: General malaise, occasional heart rate jumps and sweatsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-05
Survey response — days 1–6 daily, dose 2MedDRA: Lymph node pain — Feeling: Fair · Site: PainFree text: Lymph node pain in injection armMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-06
- 2021-04-07
- 2021-04-08
- 2021-04-09
- 2021-04-10
- 2021-04-17
- 2021-04-24
- 2021-05-01
- 2021-05-08
- 2021-05-15
- 2021-07-03
- 2021-10-02
-
2021-11-18
Dose 3 — Pfizer-BioNTech
- 2022-04-03
- 2022-05-19
-
2022-09-23
Dose 4 — Pfizer-BioNTechCo-administered: Flu
-
2022-09-24
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain · Fever · Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain, Rash, not including the immediate area around the injection site · Be unable to do your normal daily activitiesAdult check-in
-
2022-09-25
Survey response — days 1–6 daily, dose 4MedDRA: Ophthalmic migraine — Feeling: Good · Fatigue or tirednessFree text: Ocular migraineMedDRA releases: 2024-11 · check-in free text available
- 2022-09-26
- 2022-09-27
-
2022-09-28
Health check-in — days 1–6 daily, dose 4Feeling: Poor · Fever · Chills, Headache, Nausea, Abdominal pain · Be unable to do your normal daily activitiesAdult check-in
-
2022-09-29
Survey response — days 1–6 daily, dose 4MedDRA: Cough, Nausea, Oropharyngeal pain — Feeling: FairFree text: Sore throat from nausea/coughing yesterdayMedDRA releases: 2024-11 · check-in free text available
-
2022-09-30
Survey response — day 7, dose 4MedDRA: Cough, Oropharyngeal pain, SARS-CoV-2 test positive — Feeling: Poor · Chills, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Cough, sore throat, tested positive for CovidMedDRA releases: 2024-11 · check-in free text available
-
2022-10-07
Survey response — day 14, dose 4MedDRA: Appetite disorder, Chills, Fatigue, Headache, Nausea, Pyrexia, Respiratory tract congestion, Rhinorrhoea, SARS-CoV-2 test positive, Sneezing — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Tested positive for COVID-19 on 9/30/2022. Fever, headache, nausea, fatigue, chills, congestion, runny nose, sneezing, appetite changes. Symptoms have improved, but a rapid test 10/7/2022 still shows a faint positive.MedDRA releases: 2024-11 · check-in free text available
- 2022-10-14
- 2022-10-21
-
2022-10-28
Survey response — day 35, dose 4MedDRA: Diarrhoea, Respiratory tract congestion, Rhinorrhoea, Sneezing — Feeling: FairFree text: Congestion, runny nose, sneezing, diarrheaMedDRA releases: 2024-11 · check-in free text available
-
2022-11-04
Survey response — day 42, dose 4MedDRA: Throat irritation, Tonsillar hypertrophy — Feeling: GoodFree text: Tonsil swelling one side and throat irritationMedDRA releases: 2024-11 · check-in free text available
- 2022-12-23
- 2023-03-24
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-13 | Pfizer-BioNTech | |
| 2 | 2021-04-03 | Pfizer-BioNTech | |
| 3 | 2021-11-18 | Pfizer-BioNTech | No |
| 4 | 2022-09-23 | Pfizer-BioNTech | Flu |
Free text
Release 5 — day 0, dose 1
Systemic reaction (other): Headache pre-existing due to seasonal allergies
Release 5 — days 1–6 daily, dose 1
Systemic reaction (other): Restlessness
Release 6 — days 1–6 daily, dose 2
Systemic reaction (other): General malaise, occasional heart rate jumps and sweats
Release 7 — days 1–6 daily, dose 2
Systemic reaction (other): Lymph node pain in injection arm
Release 12 — days 1–6 daily, dose 4
Systemic reaction (other): Ocular migraine
Systemic reaction (other): Sore throat from nausea/coughing yesterday
Release 12 — day 7, dose 4
Systemic reaction (other): Cough, sore throat, tested positive for Covid
Release 12 — day 14, dose 4
Symptoms: Tested positive for COVID-19 on 9/30/2022. Fever, headache, nausea, fatigue, chills, congestion, runny nose, sneezing, appetite changes. Symptoms have improved, but a rapid test 10/7/2022 still shows a faint positive.
Release 12 — day 35, dose 4
Symptoms: Congestion, runny nose, sneezing, diarrhea
Release 12 — day 42, dose 4
Symptoms: Tonsil swelling one side and throat irritation
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Appetite disorder | · | · | ✓ |
| SD | Chills | · | · | ✓ |
| SD | Diarrhoea | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Nausea | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | SARS-CoV-2 test positive | · | · | ✓ |
| SD | Sneezing | · | · | ✓ |
| SD | Throat irritation | · | · | ✓ |
| SD | Tonsillar hypertrophy | · | · | ✓ |
| SRO | Cough | · | · | ✓ |
| SRO | Headache | ✓ | ✓ | ✓ |
| SRO | Hyperhidrosis | ✓ | ✓ | ✓ |
| SRO | Lymph node pain | ✓ | ✓ | ✓ |
| SRO | Malaise | ✓ | ✓ | ✓ |
| SRO | Nausea | · | · | ✓ |
| SRO | Ophthalmic migraine | · | · | ✓ |
| SRO | Oropharyngeal pain | · | · | ✓ |
| SRO | Pre-existing disease | ✓ | ✓ | ✓ |
| SRO | Restlessness | ✓ | ✓ | ✓ |
| SRO | SARS-CoV-2 test positive | · | · | ✓ |
| SRO | Seasonal allergy | ✓ | ✓ | ✓ |
| SRO | Tachycardia | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release